What is the recommended antibiotic regimen for a non‑MRSA infection in an adult without a documented beta‑lactam allergy?

Recommended Antibiotic Regimen for Non-MRSA Infection in Adults Without Beta-Lactam Allergy

For non-MRSA (methicillin-sensitive Staphylococcus aureus, MSSA) infections in adults without beta-lactam allergy, nafcillin or oxacillin (1-2 g IV every 4 hours) are the drugs of choice, with cefazolin (1 g IV every 8 hours) as a more convenient alternative with less bone marrow suppression. 1

First-Line Parenteral Options

The IDSA guidelines clearly establish the hierarchy for treating serious MSSA infections:

• Nafcillin or oxacillin: 1-2 g IV every 4 hours

  • These penicillinase-resistant penicillins remain the gold standard for serious MSSA infections 1
  • Most effective antistaphylococcal agents available
  • Potential drawback: bone marrow suppression with prolonged use

• Cefazolin: 1 g IV every 8 hours

  • Equally effective first-generation cephalosporin 1
  • More convenient dosing schedule (every 8 hours vs every 4 hours)
  • Less bone marrow suppression than nafcillin 1
  • Increasingly preferred in clinical practice for these practical advantages

Oral Options for Less Severe Infections

For skin and soft tissue infections or step-down therapy:

• Dicloxacillin: 500 mg PO four times daily 1

  • Oral agent of choice for MSSA in adults

• Cephalexin: 500 mg PO four times daily 1

  • Alternative oral option with good efficacy
  • Better availability in suspension form if needed

Clinical Context Matters

The choice between these agents depends on infection severity:

• Severe/invasive infections (bacteremia, endocarditis, osteomyelitis): Use parenteral nafcillin, oxacillin, or cefazolin 1
• Moderate skin/soft tissue infections: Can use oral dicloxacillin or cephalexin 1
• Impetigo: Cephalexin 250 mg four times daily or dicloxacillin 250 mg four times daily 1

Important Considerations

Why beta-lactams are critical: Research demonstrates that patients with MSSA bloodstream infections who receive optimal beta-lactam therapy have significantly decreased 90-day all-cause mortality compared to alternative agents 2. Reported beta-lactam allergies (even undocumented ones) lead to suboptimal therapy in 30% of cases 2, emphasizing the importance of confirming true allergy status.

Avoid these common pitfalls:

• Do not use vancomycin for MSSA infections in patients without true beta-lactam allergy—it is inferior to beta-lactams 3
• Clindamycin (600 mg IV every 8 hours) is bacteriostatic and has potential for cross-resistance; reserve for true penicillin allergy 1
• Trimethoprim-sulfamethoxazole has poorly documented efficacy for serious MSSA infections 1

The evidence strongly supports beta-lactams as superior to all alternatives for MSSA infections when no contraindication exists. 3, 4